Product Description
| Cat Number | PI-220 |
|---|---|
| Category | Peptide |
| Pack Size | 500 mg |
| Description | Irreversible chymotrypsin-like serine protease inhibitor |
| Purity | ‰¥98% by TLC |
| Biomarker Target | Serine proteases |
| Sequence Three Letter Code | N-p-Tosyl-L-phenylalanine chloromethyl ketone |
| Molecular Formula | C17H18ClNO3S |
| Sl Sequence | N-p-Tosyl-L-phenylalanine chloromethyl ketone |
| Solubility | Soluble in DMSO |
| Appearance | White solid |
| Storage | Store desiccated, frozen and in the dark |
| References |
Fearnhead et al (1995) A pre-existing protease is a common effector of thymocyte apoptosis mediated by diverse stimuli, FEBS Lett. 357 242 PMID: 7835420Griscavage et al (1996) Inhibitors of the Proteasome Pathway Interfere with Induction of Nitric Oxide Synthase in Macrophages by Blocking Activation of Transcription Factor NF-kappa. Proc. Natl. Acad. Sci. USA 93(8) 3308 PMID: 8622934 Related areas_x000D_ All small molecules >All serine protease modulators >All immunology research areas > |
| Note | The product is for research use only |
Share Item: